{
    "organizations": [],
    "uuid": "90a0dbae5794f0c5aee4c3aa37b43fc09022b8c7",
    "author": "",
    "url": "https://www.reuters.com/article/brief-assembly-biosciences-presents-posi/brief-assembly-biosciences-presents-positive-interim-data-from-phase-1a-and-1b-studies-of-abi-h0731-in-hbv-patients-idUSFWN1RP06C",
    "ord_in_thread": 0,
    "title": "BRIEF-Assembly Biosciences Presents Positive Interim Data from Phase 1a and 1b Studies of ABI-H0731 in HBV Patients",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 12, 2018 / 7:35 AM / Updated 23 minutes ago BRIEF-Assembly Biosciences Presents Positive Interim Data from Phase 1a and 1b Studies of ABI-H0731 in HBV Patients Reuters Staff 1 Min Read \nApril 12 (Reuters) - Assembly Biosciences Inc: \n* ASSEMBLY BIOSCIENCES PRESENTS POSITIVE INTERIM DATA FROM PHASE 1A AND 1B STUDIES OF ABI-H0731 IN HBV PATIENTS IN A LATE-BREAKER SESSION AT THE EASL CONFERENCE \n* SAYS GENERALLY SAFE AND WELL TOLERATED; PLANNING UNDERWAY FOR PHASE 2A STUDIES BEGINNING SUMMER 2018 Source text for Eikon: Further company coverage:",
    "published": "2018-04-12T10:35:00.000+03:00",
    "crawled": "2018-04-12T11:11:04.047+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "updated",
        "minute",
        "ago",
        "bioscience",
        "present",
        "positive",
        "interim",
        "data",
        "phase",
        "1a",
        "1b",
        "study",
        "hbv",
        "patient",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "assembly",
        "bioscience",
        "inc",
        "assembly",
        "bioscience",
        "present",
        "positive",
        "interim",
        "data",
        "phase",
        "1a",
        "1b",
        "study",
        "hbv",
        "patient",
        "session",
        "easl",
        "conference",
        "say",
        "generally",
        "safe",
        "well",
        "tolerated",
        "planning",
        "underway",
        "phase",
        "2a",
        "study",
        "beginning",
        "summer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}